ANTEROGENCupistem®Cupistem®
Cell Therapy · Domestic Approval/Sales
Indication · Crohn's Fistula
An autologous cell therapy using mesenchymal stem cells derived from the patient's own adipose tissue.
View Product Info
04 PRODUCTS
Products
Anterogen's business spans cell therapies, pharmaceuticals, and cosmetic ingredients.
PRODUCT STATUSAPPROVED · MARKETED · BUSINESS AREA
Queencell®Queencell®
Advanced Biologics · Domestic Approval
Indication · Improvement of subcutaneous fat defects
A product using minimally manipulated adipocytes isolated from autologous adipose tissue.
View Product Info
Remodulin®Remodulin®
Orphan Drug · Domestic Sales
Indication · Pulmonary Arterial Hypertension
A treatment for pulmonary arterial hypertension sold domestically by Anterogen.
View Product Info
Tyvaso®Tyvaso®
Orphan Drug · Preparing for Launch
Indication · Pulmonary Hypertension associated with Interstitial Lung Disease
Preparing for launch as of Q1 2026 following domestic orphan drug approval in 2024.
SCM2Stem Cell Conditioned Media
Cosmetic Ingredient · Legacy Homepage Product
Indication · Adipose-derived MSC Conditioned Media
Cosmetic ingredient business domain based on stem cell conditioned media. Please contact the relevant department for product specifications and supply conditions.
관련 자료자료 보기 ↗
PRODUCT INFORMATION
For the proper use of approved products.
Dosage, contraindications, adverse reactions, and storage requirements follow each product guide.